Document is current
Any future updates will be listed below
-
Authors
Villanueva-Millan, Maria J.
Leite, Gabriela
Morales, Walter
Sanchez, Maritza
Parodi, Gonzalo
Weitsman, Stacy
Celly, Shreya
Cohrs, Daniel
Do, Huongly
Barlow, Gillian M.
Mathur, Ruchi
Rezaie, Ali
Pimentel, Mark https://orcid.org/0000-0002-0619-5115
-
Funding
Funding for this research was provided by:
National Philanthropic Trust
Monica Lester Charitable Trust
The Elias, Genevieve, and Georgianna Atol Charitable Trust
Cedars-Sinai Medical Center
- License Information
-
More Information
Article History
Received: 2 November 2022
Accepted: 23 August 2023
First Online: 7 December 2023
Declarations
:
: M.P. is a consultant for Bausch Health, Ferring Pharmaceuticals Inc., and Vivante Health Inc. M.P. has received grant support from Bausch Health and Synthetic Biologics. R.M. has received grant support from Valiant Pharmaceuticals. A.R. is a consultant/speaker for and has received grant support from Bausch Health. Cedars-Sinai has a licensing agreement with Gemelli Biotech. A.R., M.P., and R.M. have equity in Gemelli Biotech. All other authors report no conflict of interest.
